Gland Pharma Limited

NSEI:GLAND 株式レポート

時価総額:₹299.4b

このページの翻訳は実験的なもので、現在開発中です。お待ちしております!

Gland Pharma 将来の成長

Future 基準チェック /36

Gland Pharma利益と収益がそれぞれ年間19.7%と11.4%増加すると予測されています。EPS は年間 増加すると予想されています。自己資本利益率は 3 年後に12.5% 19.7%なると予測されています。

主要情報

19.7%

収益成長率

19.7%

EPS成長率

Pharmaceuticals 収益成長17.1%
収益成長率11.4%
将来の株主資本利益率12.5%
アナリストカバレッジ

Good

最終更新日23 May 2024

今後の成長に関する最新情報

Earnings Miss: Gland Pharma Limited Missed EPS By 15% And Analysts Are Revising Their Forecasts

May 25
Earnings Miss: Gland Pharma Limited Missed EPS By 15% And Analysts Are Revising Their Forecasts

Recent updates

Does Gland Pharma (NSE:GLAND) Have A Healthy Balance Sheet?

Jun 22
Does Gland Pharma (NSE:GLAND) Have A Healthy Balance Sheet?

Earnings Miss: Gland Pharma Limited Missed EPS By 15% And Analysts Are Revising Their Forecasts

May 25
Earnings Miss: Gland Pharma Limited Missed EPS By 15% And Analysts Are Revising Their Forecasts

Is Gland Pharma (NSE:GLAND) A Risky Investment?

Mar 19
Is Gland Pharma (NSE:GLAND) A Risky Investment?

Gland Pharma Limited's (NSE:GLAND) Share Price Matching Investor Opinion

Feb 16
Gland Pharma Limited's (NSE:GLAND) Share Price Matching Investor Opinion

Analysts' Revenue Estimates For Gland Pharma Limited (NSE:GLAND) Are Surging Higher

May 20
Analysts' Revenue Estimates For Gland Pharma Limited (NSE:GLAND) Are Surging Higher

Is Gland Pharma Limited (NSE:GLAND) Expensive For A Reason? A Look At Its Intrinsic Value

Feb 07
Is Gland Pharma Limited (NSE:GLAND) Expensive For A Reason? A Look At Its Intrinsic Value

Analysts Just Slashed Their Gland Pharma Limited (NSE:GLAND) EPS Numbers

Jul 22
Analysts Just Slashed Their Gland Pharma Limited (NSE:GLAND) EPS Numbers

Does This Valuation Of Gland Pharma Limited (NSE:GLAND) Imply Investors Are Overpaying?

Jul 14
Does This Valuation Of Gland Pharma Limited (NSE:GLAND) Imply Investors Are Overpaying?

Is Now The Time To Put Gland Pharma (NSE:GLAND) On Your Watchlist?

Feb 08
Is Now The Time To Put Gland Pharma (NSE:GLAND) On Your Watchlist?

A Look At The Intrinsic Value Of Gland Pharma Limited (NSE:GLAND)

Jul 05
A Look At The Intrinsic Value Of Gland Pharma Limited (NSE:GLAND)

Gland Pharma (NSE:GLAND) Strong Profits May Be Masking Some Underlying Issues

May 24
Gland Pharma (NSE:GLAND) Strong Profits May Be Masking Some Underlying Issues

Gland Pharma Limited (NSE:GLAND) Exceeded Expectations And The Analyst Consensus Has Been Reviewing Its Models

May 19
Gland Pharma Limited (NSE:GLAND) Exceeded Expectations And The Analyst Consensus Has Been Reviewing Its Models

Gland Pharma Limited's (NSE:GLAND) 27% Price Boost Is Out Of Tune With Earnings

Mar 04
Gland Pharma Limited's (NSE:GLAND) 27% Price Boost Is Out Of Tune With Earnings

Gland Pharma Limited's (NSE:GLAND) Stock Is Going Strong: Is the Market Following Fundamentals?

Feb 20
Gland Pharma Limited's (NSE:GLAND) Stock Is Going Strong: Is the Market Following Fundamentals?

業績と収益の成長予測

NSEI:GLAND - アナリストの将来予測と過去の財務データ ( )INR Millions
日付収益収益フリー・キャッシュフロー営業活動によるキャッシュ平均アナリスト数
3/31/202780,66613,7849,40412,5715
3/31/202671,29912,2776,56411,15711
3/31/202564,1549,616-1,77610,0767
3/31/202456,6477,7255,9859,968N/A
12/31/202349,1236,587N/AN/AN/A
9/30/202343,0546,9888323,901N/A
6/30/202339,7647,460N/AN/AN/A
3/31/202336,2467,8101,4083,640N/A
12/31/202239,4269,883N/AN/AN/A
9/30/202240,67610,2936,7479,508N/A
6/30/202241,03710,902N/AN/AN/A
3/31/202244,00712,1172,6877,908N/A
12/31/202141,85411,862N/AN/AN/A
9/30/202139,81511,1723284,688N/A
6/30/202137,32610,340N/AN/AN/A
3/31/202134,6299,9703,7626,049N/A
12/31/202032,1049,313N/AN/AN/A
6/30/202028,4309,0277,0259,058N/A
3/31/202026,3327,7295,0637,009N/A
3/31/201920,4424,5194951,853N/A
3/31/201816,1993,2111,1692,021N/A
3/31/201714,7924,137N/A4,765N/A

アナリストによる今後の成長予測

収入対貯蓄率: GLANDの予測収益成長率 (年間19.7% ) は 貯蓄率 ( 6.7% ) を上回っています。

収益対市場: GLANDの収益 ( 19.7% ) はIndian市場 ( 15.9% ) よりも速いペースで成長すると予測されています。

高成長収益: GLANDの収益は増加すると予測されていますが、大幅には増加しません。

収益対市場: GLANDの収益 ( 11.4% ) Indian市場 ( 9.5% ) よりも速いペースで成長すると予測されています。

高い収益成長: GLANDの収益 ( 11.4% ) 20%よりも低い成長が予測されています。


一株当たり利益成長率予想


将来の株主資本利益率

将来のROE: GLANDの 自己資本利益率 は、3年後には低くなると予測されています ( 12.5 %)。


成長企業の発掘